News

Cannabis and Hemp Research Firm Oasis Intelligence Names Hilary Craven, Dr. Stuart Silverman to Board

January 29, 2020

LOS ANGELES–(BUSINESS WIRE)–Officially launched to offer brand marketers, investors, and MSOs in the cannabis and hemp industry badly needed consumer insights, Oasis Intelligence announces official appointments to its Board of Advisors, Founder of Sidecar, Hilary Craven and Stuart Silverman, M.D. The Oasis Cannabis and Hemp Industry Tracker™ is the largest proprietary study of consumer attitudes,…

Details

Eaze Releases 2019 State of Cannabis Report

January 29, 2020

SAN FRANCISCO–(BUSINESS WIRE)–Eaze, California’s largest legal cannabis marketplace, today released its fifth annual Eaze Insights | State of Cannabis 2019, which looks at aggregate consumer trends driving the world’s largest cannabis market. The report’s findings are informed by the aggregated purchase data of more than 500,000 Eaze consumers across the state of California in 2019.…

Details

Post-Traumatic Stress Disorder – Pipeline Review, H1 2020 – ResearchAndMarkets.com

January 29, 2020

DUBLIN–(BUSINESS WIRE)–The “Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary The latest Pharmaceutical and Healthcare disease pipeline guide Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, H1 2020, provides an overview of the Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline landscape. Post-traumatic stress disorder (PTSD)…

Details

Obsessive-Compulsive Disorder, Pipeline Review, H1 2020: Stage of Development, Drug Target, Mechanism of Action, Route of Administration & Molecule Type – ResearchAndMarkets.com

January 29, 2020

DUBLIN–(BUSINESS WIRE)–The “Obsessive-Compulsive Disorder – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary The latest Pharmaceutical and Healthcare disease pipeline guide Obsessive-Compulsive Disorder – Pipeline Review, H1 2020, provides an overview of the Obsessive-Compulsive Disorder (Central Nervous System) pipeline landscape. Obsessive-compulsive disorder (OCD) is characterized by unreasonable thoughts and fears…

Details

Sproutly Secures $1 Million Loan

January 28, 2020

VANCOUVER, British Columbia–(BUSINESS WIRE)–Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly” or the “Company”) is pleased to announce it has secured a private loan (the “Loan”) of $1 million from Infusion Biosciences Inc., a related party of the Company (the “Lender”). The Loan carries an interest rate of 10% per annum accruing and…

Details

Innovative Industrial Properties Announces Exercise of Option to Purchase Additional Shares of Common Stock

January 28, 2020

SAN DIEGO–(BUSINESS WIRE)–Innovative Industrial Properties, Inc. (the “Company”) (NYSE: IIPR) announced today the full exercise of the underwriters’ option to purchase an additional 445,170 shares of common stock in connection with the Company’s previously announced follow-on offering that priced on January 24, 2020. In total, the Company sold 3,412,969 shares of common stock in the…

Details

Brown-Forman Declares Cash Dividend

January 28, 2020

LOUISVILLE, Ky.–(BUSINESS WIRE)–Brown-Forman Corporation’s (NYSE: BFA) (NYSE: BFB) Board of Directors declared a regular quarterly cash dividend of $0.1743 on its Class A and Class B Common Stock. Stockholders of record on March 9, 2020, will receive the cash dividend on April 1, 2020. Brown-Forman has paid regular quarterly cash dividends for 74 consecutive years…

Details

Zuna Delivers Compliant Digital Payments for Cannabis Operators Through Alt Thirty Six

January 28, 2020

SAN JOSE, Calif.–(BUSINESS WIRE)–Zuna, a leading provider of integrated solutions for cannabis cultivation management, partnered with Alt Thirty Six, the leading US cannabis payment technology, enabling compliant digital payments through it’s CannPOS (Point-of-Sale) and CannERP (Enterprise Resource Planning) platforms. Through the Alt Thirty Six integration, Zuna offers users & licensed dispensaries a compliant digital method…

Details

Canna Angels Manages Extraordinary Growth of Portfolio in Competitive Industry

January 28, 2020

SAUSALITO, Calif.–(BUSINESS WIRE)–Canna Angels LLC, a dedicated angel investment consortium at the forefront of investment opportunities in the cannabis industry, announces their three year anniversary, boasting an outstanding alumni portfolio of 52 carefully curated companies as rising stars within the cannabis industry. In less than three years, Canna Angels’ portfolio of companies has achieved five…

Details

TFF Pharmaceuticals Reports Continued Progress Across Programs in Corporate Update

January 28, 2020

AUSTIN, Texas–(BUSINESS WIRE)–TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today provided a year-end 2019 corporate update and anticipated clinical milestones for 2020. “Since our Initial Public Offering at the end of October 2019, the company…

Details

Cresco Labs Closes Sale-and-Leaseback With Innovative Industrial Properties for Ohio Facility

January 28, 2020

CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has closed on the agreement to sell its Yellow Springs, OH property to Innovative Industrial Properties, Inc. (“IIP”). The sale (previously announced on November 26th) was for approximately…

Details

Shareholder Alert: Robbins LLP Announces Geron Corporation (GERN) Sued for Misleading Shareholders

January 27, 2020

SAN DIEGO & MENLO PARK, Calif.–(BUSINESS WIRE)–Shareholder rights law firm Robbins LLP announces that a purchaser of Geron Corporation (NASDAQ: GERN) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between March 19, 2018 and September 26, 2018. Geron is a biopharmaceutical company that focuses on…

Details